Honolulu, HI

HAWAII CANCER CONSORTIUM

EIN 45-2280259

Health & Wellness Medical Research & Training Patients & families

Mission

To conduct and encourage high‑quality medical, surgical, and scientific research in cancer treatment, diagnosis, and care; and to compile and disseminate information derived from such research to improve patient outcomes.

IRS-recognized 501(c)(3) public charity Contributions are tax-deductible

Claim this page Visit hawaiicancerconsortium.info

About HAWAII CANCER CONSORTIUM

The Hawaii Cancer Consortium is a 501(c)(3) public charity based in Honolulu that coordinates and funds collaborative cancer research, clinical trials, training, and community education across Hawaiʻi. The organization is structured as a consortium of major Hawaiʻi health systems and research partners and explicitly supports the University of Hawaiʻi Cancer Center's clinical and translational research efforts.

This profile was prepared after verifying the EIN 45-2280259 against the consortium's own website and available public filings. In recent years the consortium has supplied multi-year grant support to the UH Cancer Center, supported expansion of statewide clinical trial capacity, and contributed to development of the Hoʻōla Early Phase Clinical Research Center (scheduled to open in early 2026); the consortium reported approximately $2.25M in contributions for the fiscal year ending June 30, 2025 and the UH Cancer Center reported 139 active clinical trials as of 2024.

Notable achievements

Support for early‑phase clinical trial capacity

Played a funding and partnership role in the development of the Hoʻōla Early Phase Clinical Research Center—bringing Phase 1 clinical trial capability to Hawaiʻi for the first time and improving local access to investigational therapies (center scheduled to open in early 2026).

Sustained grantmaking to local cancer research

Provided multi‑year financial support and contributions to the University of Hawaiʻi Cancer Center and affiliated research programs; the consortium reported roughly $2.25M in contributions for the fiscal year ending June 30, 2025.

Statewide clinical trial network

Coordinated a consortium of major Hawaiʻi health systems and clinical partners to increase patient accrual to national and investigator‑initiated trials, expanding trial access across the islands.

At a glance

Total assets: $1.6M
Annual revenue: $2.4M
Tax status: 501(c)(3)Public charity
EIN: 45-2280259
Location: Honolulu, HI
Website: hawaiicancerconsortium.info
On Mahalo since: September 2026

Financial figures from the IRS Business Master File, the IRS’s registry of tax-exempt organizations.

Recognition

Operates in direct partnership with the NCI‑designated University of Hawaiʻi Cancer Center and the state's major health systems, reflecting institutional recognition and integration into regional cancer research infrastructure.

Maintains active 501(c)(3) public charity status and files annual IRS Form 990s that report grantmaking and contributions supporting cancer research in Hawaiʻi.

Featured in University of Hawaiʻi Cancer Center materials and annual reporting as a principal funder and coordinating partner for clinical research and community outreach.

Is this your organization?

Claim this page to keep it current — add your logo, publish campaigns, and reach the donors and advisors discovering you on Mahalo.

Claim this page